Literature DB >> 19823823

Relevance of target cell-induced apoptosis as mechanism of resistance against natural killer cells.

Justin Hasenkamp1, Andrea Borgerding, Gerald Wulf, Norbert Schmitz, Lorenz Truemper, Bertram Glass.   

Abstract

Natural killer (NK) cells contribute to the graft-versus-leukemia effect after allogeneic stem cell transplantation. However, the efficacy of NK cell-mediated tumor cell lysis is limited due to target cell resistance, and target cell-induced apoptosis (TiA) was proposed to contribute to differences in susceptibility to NK cells. Here we analyzed the effects of target cells on the apoptosis of cytokine-activated NK cells in vitro. We found no association of target cell susceptibility and TiA of NK cells in an array of human and murine target-effector cell combinations. Incubation of NK cells with caspase inhibitors blocked TiA incompletely, indicating that TiA is partly based on caspase-independent mechanisms. Modulating NK cell susceptibility against TiA by caspase inhibition did not influence cytotoxic efficacy. Furthermore, we found cytotoxic potential of NK cells to be markedly decreased following first target cell contact. Exhaustion of NK cell activity by first target cell contact was, however, not mediated by TiA. In addition, we found no relevant TiA by lymphoma cell lines against activated murine NK cells. We conclude that TiA represents only a minor factor of target cell resistance against NK cell-mediated cytolysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19823823      PMCID: PMC2824840          DOI: 10.1007/s00277-009-0844-1

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  35 in total

1.  IL-7 prevents both caspase-dependent and -independent pathways that lead to the spontaneous apoptosis of i-IEL.

Authors:  S Yada; H Nukina; K Kishihara; N Takamura; H Yoshida; K Inagaki-Ohara; K Nomoto; T Lin
Journal:  Cell Immunol       Date:  2001-03-15       Impact factor: 4.868

2.  Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?

Authors:  Bellinda A Bladergroen; Chris J L M Meijer; Rosita L ten Berge; C Erik Hack; Jettie J F Muris; Danny F Dukers; Andreas Chott; Yoshiaki Kazama; Joost J Oudejans; Oskar van Berkum; J Alain Kummer
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

3.  Inhibition of caspases maintains the antineoplastic function of gammadelta T cells repeatedly challenged with lymphoma cells.

Authors:  M Ferrarini; G Consogno; P Rovere; C Sciorati; L Dagna; D Resta; C Rugarli; A A Manfredi
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

4.  Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence.

Authors:  C Belluco; G Esposito; R Bertorelle; R Alaggio; L Giacomelli; L C Bianchi; D Nitti; M Lise
Journal:  Eur J Surg Oncol       Date:  2002-03       Impact factor: 4.424

5.  Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.

Authors:  N Favre-Felix; A Fromentin; A Hammann; E Solary; F Martin; B Bonnotte
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

6.  Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells.

Authors:  C Lehmann; M Zeis; N Schmitz; L Uharek
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

Review 7.  KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.

Authors:  Carlos Vilches; Peter Parham
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

8.  Evidence for Fas counter attack in vivo from a study of colorectal cancer.

Authors:  E Arbuckle; N E Langlois; O Eremin; S D Heys
Journal:  Oncol Rep       Date:  2000 Jan-Feb       Impact factor: 3.906

9.  Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Authors:  Loredana Ruggeri; Marusca Capanni; Elena Urbani; Katia Perruccio; Warren D Shlomchik; Antonella Tosti; Sabrina Posati; Daniela Rogaia; Francesco Frassoni; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

Review 10.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Authors:  A Moretta; C Bottino; M Vitale; D Pende; C Cantoni; M C Mingari; R Biassoni; L Moretta
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.